Skin cancer decisions — 2024
313 indexed Board decisions in 2024.
Badges describe the whole decision, not the outcome for every condition listed. An appeal can grant one issue and deny or remand another. Check the original decision for each issue; these outcomes do not predict your claim.
- Whole decision: GrantedPACT Act · October 2024
The Veteran's prostate cancer and heart disability are granted service connection based on in-service herbicide agent exposure. The claims for tongue cancer and skin cancer are remanded due to the need to consider PACT Act provisions.
- Whole decision: Partly grantedPACT Act · October 2024
The Board granted service connection for skin cancer (basal cell carcinoma of the scalp and neck) under the PACT Act but remanded the claim for further development regarding other theories of entitlement.
- Whole decision: Remanded (sent back)October 2024
The Veteran's skin cancer is remanded due to a pre-decisional duty to assist error. An examination is needed to determine if the condition is related to service exposure and toxic exposure.
- Whole decision: DismissedOctober 2024
The Board dismissed the veteran's appeals for service connection for various conditions due to untimely filing of a VA Form 10182.
- Whole decision: Partly grantedOctober 2024
The Board dismissed the claim for service connection for hypertension as a matter of law, denied an initial compensable rating for bilateral hearing loss, and remanded claims for service connection for various conditions including a lumbar spine disorder, bilateral plantar fasciitis, vertigo, sleep apnea, skin cancer, and an acquired psychiatric disorder.
- Whole decision: DeniedOctober 2024
The Veteran's claims for service connection for skin cancer and a compensable disability rating for hypertension were denied because the new evidence submitted did not meet the threshold for being relevant to the issues at hand.
- Whole decision: DeniedOctober 2024
The Veteran's claims for service connection for skin cancer and a compensable disability rating for hypertension were denied because the new evidence submitted did not meet the threshold for readjudication, as it was not relevant to the issues at hand.
- Whole decision: DeniedOctober 2024
The Veteran's claims for service connection for skin cancer and a compensable disability rating for hypertension were denied because the new evidence submitted did not meet the threshold for readjudication, as it was not relevant to the issues at hand.
- Whole decision: GrantedOctober 2024
The Veteran's throat cancer is granted service connection based on presumed exposure to herbicide agents in Vietnam. His skin cancer and scars are also granted as secondary to his throat cancer. The earlier effective date for PTSD is denied.
- Whole decision: DeniedOctober 2024
The Board has denied service connection for multiple skin conditions and bilateral peripheral neuropathy of the four extremities, both claimed as due to herbicide exposure (Agent Orange), based on a lack of evidence establishing a causal relationship between these conditions and the Veteran's presumed in-service exposure.
- Whole decision: Remanded (sent back)October 2024
The Board has remanded the Veteran's claims due to inadequate VA examinations and the need for a new examination to assess the severity of his service-connected scars and lesions.
- Whole decision: Remanded (sent back)October 2024
The Board has remanded the Veteran's claims for service connection for various conditions due to a failure to schedule VA examinations. The Veteran was scheduled but did not attend, and good cause is found for this failure.
- Whole decision: Remanded (sent back)PACT Act · September 2024
The Board has remanded the cases for further examination and opinion regarding service connection for squamous cell carcinoma and amelanotic melanoma due to presumed herbicide exposure in Vietnam.
- Whole decision: Remanded (sent back)September 2024
The Board has remanded the claims for service connection due to a lack of VA examinations and duty-to-assist errors. The Veteran's liver disability, skin cancer, left lower extremity peripheral neuropathy, and right lower extremity peripheral neuropathy are all being reviewed.
- Whole decision: Remanded (sent back)September 2024
The Board has remanded the case due to insufficient evidence regarding the Veteran's skin cancer, specifically whether it is related to sun exposure during service in Vietnam.
- Whole decision: GrantedSeptember 2024
The Veteran's skin cancer is related to service exposure to herbicides, and the Board has granted service connection for this condition.
- Whole decision: Remanded (sent back)September 2024
The Board has remanded the case due to inadequate medical opinions and a lack of consideration of all relevant exposure bases, including ultraviolet radiation/sun exposure during service.
- Whole decision: Remanded (sent back)September 2024
The Board has remanded the Veteran's claims for coronary artery disease with valvular and hypertensive heart disease, as well as skin cancer, due to presumed herbicide exposure in Korea. The VA is required to obtain medical opinions addressing these conditions.
- Whole decision: GrantedSeptember 2024
The Veteran's malignant melanoma of the right foot is related to his service-connected punji stick injury, and the Board has granted service connection for this condition.
- Whole decision: Remanded (sent back)PACT Act · September 2024
The Veteran's claim for service connection for squamous cell carcinoma of the left central malar cheek is granted based on the PACT Act presumption. The issue of service connection for skin cancer, other than the benefit granted above, must be remanded to obtain an addendum medical opinion.
← Back to Skin cancer overview
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.